RT Journal Article
SR Electronic
T1 The impact of sampling bias on viral phylogeographic reconstruction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.12.22275024
DO 10.1101/2022.05.12.22275024
A1 Pengyu Liu
A1 Yexuan Song
A1 Caroline Colijn
A1 Ailene MacPherson
YR 2022
UL http://medrxiv.org/content/early/2022/05/13/2022.05.12.22275024.abstract
AB Genomic epidemiology plays an ever-increasing role in our understanding of and response to the spread of infectious pathogens. Phylogeography, the reconstruction of the historical location and movement of pathogens from the evolutionary relationships among sampled pathogen sequences, can inform policy decisions related to viral movement among jurisdictions. However, phylogeographic reconstruction is impacted by the fact that the sampling and virus sequencing policies differ among jurisdictions, and these differences can cause bias in phylogeographic reconstructions. Here we assess the potential impacts of geographic-based sampling bias on estimated viral locations in the past, and on whether key viral movements can be detected. We quantify the effect of bias using simulated phylogenies with known geographic histories, and determine the impact of the biased sampling and of the underlying migration rate on the accuracy of estimated past viral locations. We then apply these insights to the geographic spread of Ebolavirus in the 2014-2016 West Africa epidemic. This work highlights how sampling policy can both impact geographic inference and be optimized to best ensure the accuracy of specific features of geographic spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the grant of the Federal Government of Canada's Canada 150 Research Chair program to Prof.∼C. Colijn. A.M. is supported by a Natural Sciences and Engineering Research Council of Canada grant (RGPIN-2022-03113).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Only previously published and publicly available data was used in this manuscriptI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data for simulations and analyses conducted in this paper are available at https://github.com/pliumath/sampling-bias https://github.com/pliumath/sampling-bias